Clinical trials
Completed Pulmonary Disease, Chronic Obstructive trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
159 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 11 |
| 2012 | 5 |
| 2013 | 12 |
| 2014 | 9 |
| 2015 | 6 |
| 2016 | 8 |
| 2017 | 13 |
| 2018 | 13 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 12 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 159 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 19 |
| GlaxoSmithKline | 15 |
| Boehringer Ingelheim | 13 |
| Zhujiang Hospital | 11 |
| Guangzhou Institute of Respiratory Disease | 8 |
| Peking University Third Hospital | 8 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 6 |
| Novartis Pharmaceuticals | 6 |
| The First Affiliated Hospital of Guangzhou Medical University | 6 |
| Joincare Pharmaceutical Group Industry Co., Ltd | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 159 |
| Asthma | 9 |
| Lung Diseases | 5 |
| Bronchitis, Chronic | 4 |
| Bronchitis | 3 |
| Emphysema | 3 |
| Respiratory Insufficiency | 3 |
| Dermatitis, Atopic | 2 |
| Dyspnea | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 25 of 159. Each trial links to its page on Pharma Observatory.
59 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.